Teppei Okamoto

Hirosaki, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 110 publications

Subsequent systemic therapy initiation after first-line discontinuation in metastatic renal cell carcinoma: insights from a Japanese real-world cohort.

Subsequent systemic therapy initiation after first-line discontinuation in metastatic renal cell carcinoma: insights from a Japanese real-world cohort.

Journal: ESMO real world data and digital oncology

Published: July 13, 2026

A phase-specific benefit-toxicity framework for perioperative trials in muscle-invasive bladder cancer: A focused review andtrial-level mapping analysis.

A phase-specific benefit-toxicity framework for perioperative trials in muscle-invasive bladder cancer: A focused review andtrial-level mapping analysis.

Journal: Urologic oncology

Published: June 04, 2026

Visualizing Baseline Eligibility Across Locally Advanced or Metastatic Urothelial Cancer Trials and Real-World Cohorts.

Visualizing Baseline Eligibility Across Locally Advanced or Metastatic Urothelial Cancer Trials and Real-World Cohorts.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: May 11, 2026

Real-world Outcomes of Adjuvant Nivolumab in High-risk Bladder and Upper Tract Urothelial Carcinoma after Radical Surgery.

Real-world Outcomes of Adjuvant Nivolumab in High-risk Bladder and Upper Tract Urothelial Carcinoma after Radical Surgery.

Journal: European urology open science

Published: April 19, 2026

Real-world trends in anti-androgen prescribing and associated costs for prostate cancer in Japan: a nationwide analysis.

Real-world trends in anti-androgen prescribing and associated costs for prostate cancer in Japan: a nationwide analysis.

Journal: Japanese journal of clinical oncology

Published: April 13, 2026

Neurofibromatosis type 1 with bladder neurofibroma followed by retroperitoneal malignant peripheral nerve sheath tumor: a case report.

Neurofibromatosis type 1 with bladder neurofibroma followed by retroperitoneal malignant peripheral nerve sheath tumor: a case report.

Journal: Urology case reports

Published: March 26, 2026

Visualizing eligibility gaps between muscle-invasive bladder cancer trials and real-world patients.

Visualizing eligibility gaps between muscle-invasive bladder cancer trials and real-world patients.

Journal: Japanese journal of clinical oncology

Published: March 24, 2026

Association of EVITA with safety in advanced urothelial carcinoma: A multicenter real-world study.

Association of EVITA with safety in advanced urothelial carcinoma: A multicenter real-world study.

Journal: Urologic oncology

Published: February 16, 2026

CT-based renal artery caliber change as a potential imaging marker of treatment response in renal cell carcinoma; an exploratory imaging study.

CT-based renal artery caliber change as a potential imaging marker of treatment response in renal cell carcinoma; an exploratory imaging study.

Journal: Cancer imaging : the official publication of the International Cancer Imaging Society

Published: January 06, 2026

Overactive Bladder Symptoms as a Predictor of Longitudinal Decline in Grip Strength in Community-Dwelling Men: A 4-Year Longitudinal Study.

Overactive Bladder Symptoms as a Predictor of Longitudinal Decline in Grip Strength in Community-Dwelling Men: A 4-Year Longitudinal Study.

Journal: Lower urinary tract symptoms

Published: January 03, 2026

Presenting postoperative mortality as percentages and natural frequencies (1-in-N) in major urologic cancer surgeries.

Presenting postoperative mortality as percentages and natural frequencies (1-in-N) in major urologic cancer surgeries.

Journal: Urologic oncology

Published: December 27, 2025

Integrated Assessment of Percentage α2,3-Linked Sialylated Prostate-specific Antigen and the Prostate Health Index with Magnetic Resonance Imaging for Detection of Clinically Significant Prostate Cancer.

Integrated Assessment of Percentage α2,3-Linked Sialylated Prostate-specific Antigen and the Prostate Health Index with Magnetic Resonance Imaging for Detection of Clinically Significant Prostate Cancer.

Journal: European urology open science

Published: December 13, 2025

Showing 1-12 of 110

Last Updated: 09/26/2026